Calpain activation through galectin-3 inhibition sensitizes prostate cancer cells to cisplatin treatment

Evidence of Heavy Methylation in the Galectin 3 Promoter in Early Stages of Prostate Adenocarcinoma: Development and Validation of a Methylated Marker for Early Diagnosis of Prostate Cancer

(2014) Hafiz Ahmed et al.   Translational Oncology

Regulation of Prostate Cancer Progression by Galectin-3

(2009) Yi Wang et al.   AMERICAN JOURNAL OF PATHOLOGY

Calcium dysregulation induces apoptosis-inducing factor release: Cross-talk between PARP-1- and calpain- signaling pathways

(2009) Peter S. Vosler et al.   EXPERIMENTAL NEUROLOGY

Galectin-3 Expression in Tumor Progression and Metastasis of Papillary Thyroid Carcinoma

(2008) Hüseyin K. Türköz et al.   ENDOCRINE PATHOLOGY

Calpain-mediated pathway dominates cisplatin-induced apoptosis in human lung adenocarcinoma cells as determined by real-time single cell analysis

(2008) Lei Liu et al.   INTERNATIONAL JOURNAL OF CANCER

Calpain-mediated androgen receptor breakdown in apoptotic prostate cancer cells

(2008) Huanjie Yang et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Differential mechanisms of bicalutamide-induced apoptosis in prostate cell lines

(2008) M St John Floyd et al.   PROSTATE CANCER AND PROSTATIC DISEASES